Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Oncology Institute ( (TOI) ) has provided an announcement.
On January 2, 2026, The Oncology Institute, Inc. filled a vacancy on its board of directors by appointing Mark D. Stolper, a veteran public-company executive and current CFO of RadNet, Inc., as an independent director and chairman of the audit committee, a move publicly announced on January 5, 2026. Stolper, who will serve as the audit committee’s designated financial expert and participate in the company’s standard non-employee director compensation program, brings extensive capital markets, financial planning, and healthcare services experience that is expected to bolster TOI’s financial oversight and support its next phase of growth in value-based oncology care.
The most recent analyst rating on (TOI) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Oncology Institute stock, see the TOI Stock Forecast page.
Spark’s Take on TOI Stock
According to Spark, TipRanks’ AI Analyst, TOI is a Neutral.
The overall stock score is primarily influenced by significant financial challenges, including negative equity and profitability issues. While the earnings call provided positive guidance and strategic advancements, these are overshadowed by the company’s financial instability and weak technical indicators.
To see Spark’s full report on TOI stock, click here.
More about Oncology Institute
The Oncology Institute, Inc. (NASDAQ: TOI) is one of the largest value-based oncology groups in the United States, founded in 2007 and focused on delivering specialized, evidence-based cancer care in community settings. Serving a population of about 1.9 million patients, it offers services including clinical trials, transfusions and other advanced care delivery models through over 180 employed and affiliate clinicians and more than 100 clinics and affiliate locations across five states, positioning itself as a growth-oriented player in community oncology.
Average Trading Volume: 2,291,566
Technical Sentiment Signal: Buy
Current Market Cap: $385.7M
See more data about TOI stock on TipRanks’ Stock Analysis page.